Naomi Kresge
-
Novo, Lilly Slip As Biden Urges Price Cuts On Obesity Drugs
Novo Nordisk A/S and Eli Lilly & Co. shares fell early Tuesday after US President Joe Biden demanded price cuts on their blockbuster drugs for diabetes and weight loss.
-
Novo, Lilly Slip As Biden Urges Price Cuts On Obesity Drugs
Novo Nordisk A/S and Eli Lilly & Co. shares fell early Tuesday after US President Joe Biden demanded price cuts on their blockbuster drugs for diabetes and weight loss.
-
The Ozempic Effect: How A Weight Loss Wonder Drug Gobbled Up An Entire Economy
The blockbuster drug producer is Europe’s most valuable company —and its home country is feeling the effects.
-
Ozempic May Force Junk Food Makers To Rewrite Their Game Plans
Nearly three out of four respondents said companies making or marketing sugary, fatty or ultra-processed foods should revise their game plans.
-
AI Can Speed Drug Discovery. But Is It Really Better Than a Human?
Machine learning and molecular image recognition are far faster than researchers at identifying potential treatments. That doesn’t mean those meds will be more effective.
-
Roche Hunts For More Deals To Challenge Lilly, Novo On Obesity
Roche Holding AG isn’t done making moves in the obesity market after last month’s agreement to buy Carmot Therapeutics Inc. for as much as $3.1 billion.
-
Roche Hunts For More Deals To Challenge Lilly, Novo On Obesity
Roche Holding AG isn’t done making moves in the obesity market after last month’s agreement to buy Carmot Therapeutics Inc. for as much as $3.1 billion.
-
Wegovy Study Bolsters Use In Patients With Obesity And Heart Disease
Novo Nordisk A/S unveiled details from a closely watched study that support use of Wegovy, its blockbuster weight-loss drug, to cut heart attacks and strokes in obesity patients with a history of cardiovascular disease.
-
BioNTech Sinks As Covid-19 Vaccine Sales And Profit Disappoint
BioNTech said its omicron-adapted Covid-19 vaccines should be ready in time for fall booster campaigns.
-
War in Ukraine Is Slowing Work on Roche Multiple Sclerosis Drug
War in Ukraine Is Slowing Work on Roche Multiple Sclerosis Drug
-
Scholz Defeated as German Lawmakers Reject Mandatory Covid Shots
Scholz Defeated as German Lawmakers Reject Mandatory Covid Shots
-
Scholz Defeated as German Lawmakers Reject Mandatory Covid Shots
Scholz Defeated as German Lawmakers Reject Mandatory Covid Shots
-
German Lawmakers Propose Mandatory Covid Shots for Elderly
German Lawmakers Propose Mandatory Covid Shots for Elderly
-
Fourth Covid Shots Recommended Only for Those 80 and Over in EU
Fourth Covid Shots Recommended Only for Those 80 and Over in EU
-
Serious Covid Linked to Higher Risk of Depression Months Later
Serious Covid Linked to Higher Risk of Depression Months Later
